CT Image Analysis Software - CT CCTA

United Imaging Intelligence
The CT CCTA application is intended to assist in confirming and evaluating the presence or absence of coronary lesions for CCTA images.
CT CCTA
Information source: Vendor
Last updated: April 30, 2025

General Information

General
Product name CT Image Analysis Software - CT CCTA
Company United Imaging Intelligence
Subspeciality Cardiac
Modality CT
Disease targeted Coronary lesions, stenosis, coronary plaque
Key-features Reconstructed images (MPR/VR/MIP/Probe/CPR/SCPR), Segmentation and 3D reconstruction of heart and coronary arteries, stenosis detection, plaque detection, coronary lesion detection, plaque analysis, stenosis evaluation, pericoronary fat measurement
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps),
During: interactive decision support (shows abnormalities/results only on demand),
During: report suggestion

Technical Specifications

Data characteristics
Population Adult patients (18–120 years). Contraindicated in patients with iodine allergy, severe cardiac/renal/pulmonary dysfunction, arrhythmia, congenital heart disease, pacemakers, defibrillators, or artificial heart valves. Use with caution in case of: 1. Poor image quality (e.g., motion, beam-hardening, blooming, or interpolation artifacts). 2. Excessive image noise or suboptimal contrast filling.
Input Coronary CTA
Input format DICOM
Output Reconstructed images (MPR/VR/MIP/Probe/CPR/SCPR), segmentation of heart and coronary arteries, lesion list, table of quantified values, draft radiology report
Output format
Technology
Integration Stand-alone webbased
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time

Regulatory

Certification
CE
Certified, Class IIa , MDR
FDA 510(k) cleared
Intended Use Statements
Intended use (according to CE) The CT CCTA application is intended to assist in confirming and evaluating the presence or absence of coronary lesions for CCTA images.

Market

Market presence
On market since
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, subscription, one-time license fee
Based on Number of users, number of installations, number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers